Literature DB >> 11137523

Citrullinemia type II in a 64-year-old man with fluctuating serum citrulline levels.

H Maruyama1, M Ogawa, T Nishio, K Kobayashi, T Saheki, N Sunohara.   

Abstract

We describe a 64-year-old man with 'citrullinemia type II' whose serum citrulline levels fluctuated between normal and abnormally high during episodic manifesting periods. Elevations of the serum threonine/serine ratio and pancreatic secretory trypsin inhibitor level are very useful diagnostic markers. Our patient's cerebrospinal fluid citrulline level was also elevated, and T1-weighted magnetic resonance images revealed high-intensity signals at the bilateral internal capsule and the cerebral peduncles. Single-photon emission computed tomography of his brain showed reduced bilateral temporal lobar blood flow. Even if the serum citrulline level is within the normal range, citrullinemia should be considered in adult patients without primary liver dysfunction who show episodic consciousness disturbance, psychotic symptoms or both.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137523     DOI: 10.1016/s0022-510x(00)00449-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  2 in total

1.  Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.

Authors:  Kiyoshi Hayasaka; Chikahiko Numakura; Mitsunori Yamakawa; Tetsuo Mitsui; Hisayoshi Watanabe; Hiroaki Haga; Masahide Yazaki; Hiromasa Ohira; Yasuo Ochiai; Toshiyuki Tahara; Tamio Nakahara; Noriyo Yamashiki; Takahiro Nakayama; Takashi Kon; Hiroshi Mitsubuchi; Hiroshi Yoshida
Journal:  J Inherit Metab Dis       Date:  2018-04-12       Impact factor: 4.982

Review 2.  Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency.

Authors:  Takeyori Saheki; Keiko Kobayashi; Mikio Iijima; Ikumi Nishi; Tomotsugu Yasuda; Naoki Yamaguchi; Hong Zhi Gao; Md Abdul Jalil; Laila Begum; Meng Xian Li
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.